BIO Submits Comments on “Myriad” PTO Patent Guidance
On July 31st, BIO, alongside a group of international bioindustry trade associations submitted comments to the United States Patent and Trademark Office regarding their March 4, 2014 Guidance on patent...
View ArticlePTO Patent Examinations in the wake of Mayo and Myriad
Biotech patent applicants are finding themselves in uncharted waters. After the Supreme Court’s decisions in Mayo Collaborative Svs. v. Prometheus Labs and Ass’n for Molecular Pathology v. Myriad...
View ArticleDetailed Report Examines the Crucial Role of Patents in Genetic Testing
In The Critical Role of Patents in the Development, Commercialization, and Utilization of Innovative Genetic Diagnostic Tests, Professor Holman argues that advocates for weakening patent protection...
View ArticleBIO Deputy General Counsel Remarks on Revised Eligibility Guidance
Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property recently spoke at the U.S. Patent and Trademark Office’s public forum on patent-eligible subject matter. The forum was a chance for...
View ArticleBIO IPCC Spring Conference Program Announced
BIO’s 2015 IP Counsels Committee Spring Conference & Meeting will be held April 15-17 in St. Louis, Missouri, at the Four Seasons St. Louis Hotel. The biannual conference offers timely, relevant...
View ArticleBIO and University Organizations offer Support of STRONG Patents Act
On March 4, 2015, Senator Chris Coons (D-DE) introduced a new bill, The STRONG Patents Act of 2015. Sponsored alongside Sen. Richard Durbin (D-IL) and Sen. Mazie Hirono (D-HI), the bill is offered as a...
View Article
More Pages to Explore .....